Patents by Inventor Prabhudas Bodhuri

Prabhudas Bodhuri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8765976
    Abstract: There is provided crystalline solvate forms of Warfarin potassium, termed APO-I and APO-II, and processes for making APO-I and APO-II. APO-I and APO-II are polymorphic solvate forms of Warfarin potassium.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: July 1, 2014
    Assignee: Apotex Pharmachem Inc.
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga, Keshava K. S. Murthy
  • Publication number: 20130143957
    Abstract: There is provided crystalline solvate forms of Warfarin potassium, termed APO-I and APO-II, and processes for making APO-I and APO-II. APO-I and APO-II are polymorphic solvate forms of Warfarin potassium.
    Type: Application
    Filed: May 20, 2011
    Publication date: June 6, 2013
    Applicant: APOTEX PHARMACHEM INC.
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga, Keshava K.S. Murthy
  • Patent number: 8435989
    Abstract: Provided are process for the preparation of (R)- and/or (S)-Rivaroxaban, and compounds which are intermediate compounds used in the processes for the preparation of (R)- and/or (S)-Rivaroxaban.
    Type: Grant
    Filed: November 12, 2012
    Date of Patent: May 7, 2013
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga
  • Patent number: 8309547
    Abstract: Provided are process for the preparation of (R)- and/or (S)-Rivaroxaban, and compounds which are intermediate compounds used in the processes for the preparation of (R)- and/or (S)-Rivaroxaban.
    Type: Grant
    Filed: October 18, 2010
    Date of Patent: November 13, 2012
    Assignee: Apotex Pharmachem Inc.
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga
  • Patent number: 8101609
    Abstract: This invention provides a process for the preparation of S-Rivaroxaban and/or R-Rivaroxaban comprising reacting, in the presence of a first base, a compound of Formula 9: with a compound of Formula 8:
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: January 24, 2012
    Assignee: Apotex Pharmachem Inc.
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga
  • Publication number: 20110034465
    Abstract: Provided are process for the preparation of (R)- and/or (S)-Rivaroxaban, and compounds which are intermediate compounds used in the processes for the preparation of (R)- and/or (S)-Rivaroxaban.
    Type: Application
    Filed: October 18, 2010
    Publication date: February 10, 2011
    Applicant: APOTEX PHARMACHEM INC.
    Inventors: Prabhudas BODHURI, Gamini Weeratunga
  • Publication number: 20100273798
    Abstract: This invention provides a process for the preparation of S-Rivaroxaban and/or R-Rivaroxaban comprising reacting, in the presence of a first base, a compound of Formula 9: with a compound of Formula 8:
    Type: Application
    Filed: April 28, 2009
    Publication date: October 28, 2010
    Applicant: APOTEX PHARMACHEM INC.
    Inventors: Prabhudas BODHURI, Gamini Weeratunga
  • Publication number: 20100273790
    Abstract: This invention provides a process for the preparation of S-Rivaroxaban and/or R-Rivaroxaban comprising reacting, in the presence of a first base, a compound of Formula 9: with a compound of Formula 8: .
    Type: Application
    Filed: April 26, 2010
    Publication date: October 28, 2010
    Applicant: Apotex Pharmachem Inc.
    Inventors: Prabhudas BODHURI, Gamini Weeratunga
  • Patent number: 7816355
    Abstract: This invention provides a process for the preparation of S-Rivaroxaban and/or R-Rivaroxaban comprising reacting, in the presence of a first base, a compound of Formula 9: with a compound of Formula 8:
    Type: Grant
    Filed: April 28, 2009
    Date of Patent: October 19, 2010
    Assignee: Apotex Pharmachem Inc
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga
  • Publication number: 20100168111
    Abstract: A polymorphic form of rivaroxaban, 5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide (termed form APO-A), processes for the preparation thereof, and compositions and formulations comprising form APO-A are provided. Also provided are compositions comprising a crystalline form of rivaroxaban and solvents selected from C3 to C6 ketones, C3 to C4 amides and mixtures thereof.
    Type: Application
    Filed: December 31, 2008
    Publication date: July 1, 2010
    Applicant: Apotex Pharmachem Inc.
    Inventors: Prabhudas Bodhuri, Gamini Weeratunga